Stay updated on SB414 PK, PD, Safety in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.

Latest updates to the SB414 PK, PD, Safety in Psoriasis Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe page shows a new Revision: v3.4.2 and removes the previous funding/operating-status notice and Revision: v3.4.1.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about potential delays due to a lapse in government funding and updated the page revision from 3.4.0 to 3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedUI and metadata updates include a new 'Show glossary' option and a new 'Last Update Submitted that Met QC Criteria' field in Study Dates (replacing the prior lowercase variant). The footer now shows 'Revision: v3.4.0' and 'No FEAR Act Data' with corrected capitalization, replacing the previous 'No FEAR Act data' and 'Revision: v3.3.4'.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4; no substantive changes to the study record are evident.SummaryDifference0.1%

- Check64 days agoChange DetectedA centralized Locations section now lists Idaho, Texas, and Virginia as study sites, replacing the prior state-specific location subsections, and the page revision is updated to v3.3.3.SummaryDifference0.5%

- Check92 days agoChange DetectedThe top of the page now shows Revision: v3.3.2, replacing Revision: v3.2.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to SB414 PK, PD, Safety in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SB414 PK, PD, Safety in Psoriasis Clinical Trial page.